Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Aged. Found 457 abstracts

no pagination
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug;98(5):1028-35.   PMCID: PMC5572128
Balar AV, Castellano D, O'Donnell PH, Grivas P, Vuky J, Powles T, Plimack ER, Hahn NM, de Wit R, Pang L, Savage MJ, Perini RF, Keefe SM, Bajorin D, Bellmunt J. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 Sep 26;18(11):1483-92.
Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2017 Aug;40(4):393-8.   PMCID: PMC5026539
Choueiri TK, Plimack E, Arkenau HT, Jonasch E, Heng DY, Powles T, Frigault MM, Clark EA, Handzel AA, Gardner H, Morgan S, Albiges L, Pal SK. Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10;35(26):2993-3001.
Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evans A, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 Nov 15;123(22):4411-8.
Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters M, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DS, Wang HJ, Elashoff DA, Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. The New England journal of medicine. 2017 Jun 08;376(23):2211-22.   PMCID: PMC5548388
Gore JL, du Plessis M, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher Test Impacts Decision Making Among Patients Considering Adjuvant and Salvage Treatment After Radical Prostatectomy: Interim Results From the Multicenter Prospective PRO-IMPACT Study. Cancer. 2017 Aug;123(15):2850-9.   PMCID: PMC5573983
Haas NB, Manola J, Dutcher JP, Flaherty KT, Uzzo RG, Atkins MB, DiPaola RS, Choueiri TK. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. JAMA Oncol. 2017 Sep;3(9):1249-52.   PMCID: PMC5591751
Hellmann MD, Rizvi NA, Goldman JW, Gettinger SN, Borghaei H, Brahmer JR, Ready NE, Gerber DE, Chow LQ, Juergens RA, Shepherd FA, Laurie SA, Geese WJ, Agrawal S, Young TC, Li X, Antonia SJ. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Lancet Oncol. 2017 Jan;18(1):31-41.   PMCID: PMC5476941
Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CA, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. Cancer. 2017 Jul;123(13):2489-96.   PMCID: PMC5474197
Kantarjian HM, Roboz GJ, Kropf PL, Yee KW, O'Connell CL, Tibes R, Walsh KJ, Podoltsev NA, Griffiths EA, Jabbour E, Garcia-Manero G, Rizzieri D, Stock W, Savona MR, Rosenblat TL, Berdeja JG, Ravandi F, Rock EP, Hao Y, Azab M, Issa JJ. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. Lancet Oncol. 2017 Aug 24;18(10):1317-26.
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, Brca, Brca Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama. 2017 Jun 20;317(23):2402-16.
Lawton CA, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun;98(2):296-303.   PMCID: PMC5603177
Lazar AJ, McLellan MD, Bailey MH, Miller CA, Appelbaum EL, Cordes MG, Fronick CC, Fulton LA, Fulton RS, Mardis ER, Schmidt HK, Wong W, Wilson RK, Yellapantula V, Radenbaugh AJ, Hoadley KA, Hayes DN, Parker JS, Wilkerson MD, Auma JT, Balu S, Bodenheimer T, Hoyle AP, Jefferys SR, Jones CD, Lehmann KV, Meng SW, Mieczkowski PA, Mose LE, Perou CM, Roach J, Senbabaoglu Y, Shi Y, Simons JV, Skelly T, Soloway MG, Tan DH, Veluvolu U, Davis IJ, Hepperla AJ, Brohl AS, Kasaian K, Mungall K, Sadeghi S, Barthel FP, Verhaak R, Hu X, Chibon F, Cherniack AD, Shih J, Beroukhim R, Meyerson M, Cibulskis C, Gabriel SB, Saksena G, Schumacher SE, Bailey MH, Gao QS, Wong WH, Wyczalkowski M, Bowlby R, Robertson AG, Ally A, Balasundaram M, Brooks D, Carlsen R, Chuah E, Dhalla N, Holt RA, Jones SJ, Lee D, Li I, Ma Y, Marra MA, Mayo M, Moore RA, Mungall AJ, Parker JS, Schein JE, Sipahimalani P, Tam A, Thiessen N, Wong T, Danilova L, Cope L, Baylin SB, Bootwalla MS, Lai PH, Laird PW, Maglinte DT, Van Den Berg DJ, Weisenberger DJ, Wrangle J, Drill E, Shen RL, Iype L, Reynolds SM, Shmulevich I, Yau C, Armenia J, Liu EM, Benz C, Pastore A, Sanchez-Vega F, Schultz N, Akbani R, Hegde AM, Liu WB, Lu Y, Mills GB, Weinstein JN, Roszik J, Anur P, Spellman P, Abeshouse A, Chen HW, Gao J, Heins Z, Kundra R, Larsson E, Ochoa A, Sanchez-Vega F, Sander C, Schultz N, Socci N, Zhang HX, Noble MS, Heiman DI, Kim J, Chin L, Getz G, Cho J, Defreitas T, Frazer S, Gehlenborg N, Lawrence MS, Lin P, Meier S, Voet D, Zhang HL, Byers L, Diao LX, Gay CM, Wang J, Newton Y, Cooper LA, Gutman DA, Lazar AJ, Lee S, Nalisnik M, Bowen J, Gastier-Foster JM, Gerken M, Helsel C, Hobensack S, Leraas KM, Lichtenberg TM, Ramirez NC, Wise L, Zmuda E, Anderson ML, Castro P, Ittmann M, Gordienko E, Paklina O, Setdikova G, Raut CP, Karlan BY, Lester J, Belyaev D, Fulidou V, Potapova O, Voronina O, Demetri GD, Ramalingam SS, Behera M, Delman K, Owonikoko TK, Sica GL, Boyd J, Magliocco A, Salner A, Bennett J, Iacocca M, Swanson P, Dottino P, Kalir T, Pereira E, Akeredolu T, Crain D, Curley E, Gardner J, Mallery D, Morris S, Paulauskis J, Penny R, Shelton C, Shelton T, Thompson E, Hoon DB, Parfitt J, Birrer M, Karseladze A, Mariamidze A, Dao F, Levine DA, Olvera N, Maki RG, Bartlett J, Eschbacher J, Dubina M, Mozgovoy E, Fedosenko K, Manikhas G, Sekhon H, Ramirez N, Lazar AJ, Ingram DR, Torres KE, DiSaia P, Godwin AK, Godwin EM, Kuo H, Madan R, Reilly C, Adebamowo C, Adebamowo SN, Bocklage T, Higgins K, Martinez C, Auman JT, Boice L, Grilley-Olson JE, Huang M, Perou AH, Thorne LB, Rathmell WK, Gutmann DH, Singer S, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan YH, Wu Y, Felau I, Zenklusen JC, Demchok JA, Ferguson ML, Hutter CM, Sofia HJ, Tarnuzzer R, Wang ZN, Yang LM, Zhang JS, Demicco EG, Doyle LA, Hornick JL, Lazar AJ, Rubin BP, de Rijn MV, Demetri GD, Baker L, Grilley-Olson JE, Iype L, Lazar AJ, Lichtenberg TM, Raut CP, Riedel RF, Demicco EG, Ding L, Ladanyi M, Lazar AJ, Novak JE, Sanchez-Vega F, Singer S, Van Tine BA, Byers L, Cope L, Cherniack AD, Cooper LA, Davis IJ, Davis LE, Demetri GD, Doyle LA, Drill E, Godwin AK, Grilley-Olsen JE, Gutmann DH, Hayes DN, Hepperla AJ, Hoadley KA, Hoon DB, Hornick JL, Iype L, Kim J, Maki RG, Pollock RE, Raut CP, Riedel RF, Robertson AG, Rubin BP, Shih J, Weinstein JN, Wong WH, Akbani R, Anderson ML, Anur P, Bailey MH, Benz C, Bowen J, Bowlby R, Brohl AS, Cherniack AD, Cooper LA, Cope L, Danilova L, Davis LE, Demetri GD, Gay CM, Godwin AK, Grilley-Olson JE, Gutman DA, Hegde AM, Jones KB, Kasaian K, Ladanyi M, Lazar AJ, Lee S, Leraas KM, Lichtenberg TM, Martignetti JA, McLellan MD, Miller CA, Mungall K, Nalisnik M, Noble MS, Raut CP, Riedel RF, Robertson AG, Roszik J, Sadeghi S, Sanchez-Vega F, Shen RL, Shih J, Tong P, Torres KE, Yau C, Zenklusen JC, Canc Genome Atlas Res N. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov;171(4):950-965 e28.   PMCID: PMC5693358
Liederbach E, Kyrillos A, Wang CH, Liu JC, Sturgis EM, Bhayani MK. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma. International journal of cancer. 2017 Feb;140(3):504-12.
Lynch SM, Mitra N, Ross M, Newcomb C, Dailey K, Jackson T, Zeigler-Johnson CM, Riethman H, Branas CC, Rebbeck TR. A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness. PLoS One. 2017 Jan;12(3):e0174548.   PMCID: PMC5367705
Mirhadi AJ, Zhang Q, Hanks GE, Lepor H, Grignon DJ, Peters CA, Rosenthal SA, Zeitzer K, Radwan JS, Lawton C, Parliament MB, Reznik RS, Sandler HM. Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Mar;97(3):511-5.   PMCID: PMC5485922
Moore KN, Martin LP, O'Malley DM, Matulonis UA, Konner JA, Perez RP, Bauer TM, Ruiz-Soto R, Birrer MJ. Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. J Clin Oncol. 2017 Apr;35(10):1112-8.   PMCID: PMC5559878
Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States. Blood. 2017 Jul 03;130(9):1156-64.   PMCID: PMC5580273
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Aged

Aged Middle Aged pathology Male Adult Disease-Free Survival 80 and over Aged Female therapeutic use adverse effects mortality drug therapy Treatment Outcome Neoplasm Staging administration & dosage methods Prognosis Prospective Studies therapy Adenocarcinoma Prostatic Neoplasms diagnosis Survival Analysis Neoplasm Invasiveness genetics Kaplan-Meier Estimate surgery Time Factors Drug Administration Schedule Risk Assessment analogs & derivatives Young Adult Cohort Studies Survival Rate Androgen Antagonists blood Follow-Up Studies Drug Dose-Response Relationship Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Neoplasm Grading Multivariate Analysis Retrospective Studies radiotherapy Prostate-Specific Antigen Conformal Radiotherapy Hematopoietic Stem Cell Transplantation Age Factors epidemiology Incidence Prostatectomy Maximum Tolerated Dose Patient Safety Intensity-Modulated Radiotherapy Squamous Cell Carcinoma diagnostic imaging Risk Factors Kidney Neoplasms antagonists & inhibitors Combined Modality Therapy Breast Neoplasms statistics & numerical data Neoplasm Drug Resistance Monoclonal Antibodies-Humanized Mutation Ovarian Neoplasms Radiation Injuries Intravenous Infusions Renal Cell Carcinoma Salvage Therapy secondary Proportional Hazards Models etiology Nitriles decisional conflict Intention to Treat Analysis Conflict (Psychology) Fatigue Surveys and Questionnaires Chemoradiotherapy Oropharyngeal Neoplasms immune infiltration Hypotension high risk Continental Population Groups head and neck cancer Oropharynx Cisplatin Phenylurea Compounds prostate cancer Tosyl Compounds Remission Induction Flutamide Transitional Cell Carcinoma Lymphedema Residence Characteristics Demography Adjuvant Chemoradiotherapy Local Neoplasm Recurrence Fallopian Tube Neoplasms non-Hodgkin lymphoma Non-Small-Cell Lung Carcinoma Health Services Accessibility genomics Pancreatic Neoplasms Taxoids Piperidines Tumor Biomarkers undifferentiated pleomorphic sarcoma Anilides postprostatectomy Sarcoma chemotherapy Intraductal Carcinoma-Noninfiltrating DNA methylation Pyrroles Fibrosis squamous cell carcinoma Paclitaxel Sentinel Lymph Node Radiation Oncology Prevalence leiomyosarcoma myxofibrosarcoma Social Support Myeloid Leukemia-Acute myc Genes physiopathology Oral Administration Age Distribution Double-Blind Method adjuvant therapy Lymph Nodes Papillomavirus Infections Reoperation hematopoietic cell transplantation (HCT) Quinazolines human papillomavirus Fluorouracil Predictive Value of Tests Internationality molecular subtype Retreatment United States radiation effects BRCA2 Genes androgen deprivation diffuse large B-cell lymphoma (DLBCL) Platinum Compounds Gonadotropin-Releasing Hormone
Last updated on Friday, January 05, 2018